These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 17692922

  • 1. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
    Ray D, Goswami R, Dadhwal V, Goswami D, Banerjee U, Kochupillai N.
    J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Sreenivas V, Kochupillai N.
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [Abstract] [Full Text] [Related]

  • 3. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
    Goswami D, Goswami R, Banerjee U, Dadhwal V, Miglani S, Lattif AA, Kochupillai N.
    J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
    [Abstract] [Full Text] [Related]

  • 4. [Combined single-day treatment in acute vulvovaginal candidosis].
    Kovachev S, Nacheva A, Vacheva-Dobrevska R, Vasilev N.
    Akush Ginekol (Sofiia); 2009 Feb; 48(6):18-23. PubMed ID: 20225492
    [Abstract] [Full Text] [Related]

  • 5. Clinical and mycological efficacy of single-day oral treatment with itraconazole (400 mg) in acute vulvovaginal candidosis.
    Urünsak M, Ilkit M, Evrüke C, Urünsak I.
    Mycoses; 2004 Oct; 47(9-10):422-7. PubMed ID: 15504127
    [Abstract] [Full Text] [Related]

  • 6. [Comparative study of itraconazole and fluconazole therapy in vaginal candidosis].
    Vacheva-Dobrevski R, Kovachev S, Nacheva A, Stoev S, Vasilev N.
    Akush Ginekol (Sofiia); 2004 Oct; 43(1):20-3. PubMed ID: 15168649
    [Abstract] [Full Text] [Related]

  • 7. Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis.
    Sood G, Nyirjesy P, Weitz MV, Chatwani A.
    Infect Dis Obstet Gynecol; 2000 Oct; 8(5-6):240-3. PubMed ID: 11220485
    [Abstract] [Full Text] [Related]

  • 8. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
    Seidman LS, Skokos CK.
    Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
    [Abstract] [Full Text] [Related]

  • 9. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial).
    Donders G, Bellen G, Byttebier G, Verguts L, Hinoul P, Walckiers R, Stalpaert M, Vereecken A, Van Eldere J.
    Am J Obstet Gynecol; 2008 Dec; 199(6):613.e1-9. PubMed ID: 18976735
    [Abstract] [Full Text] [Related]

  • 10. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence.
    Iavazzo C, Gkegkes ID, Zarkada IM, Falagas ME.
    J Womens Health (Larchmt); 2011 Aug; 20(8):1245-55. PubMed ID: 21774671
    [Abstract] [Full Text] [Related]

  • 11. [Short-course treatment of vulvovaginal candidiasis: comparative study of fluconazole and intra-vaginal fenticonazole].
    Murina F, Graziottin A, Felice R, Di Francesco S, Mantegazza V.
    Minerva Ginecol; 2012 Apr; 64(2):89-94. PubMed ID: 22481619
    [Abstract] [Full Text] [Related]

  • 12. FLUCONAZOLE AND BORIC ACID FOR TREATMENT OF VAGINAL CANDIDIASIS--NEW WORDS ABOUT OLD ISSUE.
    Khameneie KM, Arianpour N, Roozegar R, Aklamli M, Amiri MM.
    East Afr Med J; 2013 Apr; 90(4):117-23. PubMed ID: 26866095
    [Abstract] [Full Text] [Related]

  • 13. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
    Fan SR, Liu XP.
    Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis.
    Guaschino S, De Seta F, Sartore A, Ricci G, De Santo D, Piccoli M, Alberico S.
    Am J Obstet Gynecol; 2001 Mar; 184(4):598-602. PubMed ID: 11262459
    [Abstract] [Full Text] [Related]

  • 15. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W, Brasch J, Cornely OA, Effendy I, Friese K, Ginter-Hanselmayer G, Hof H, Mayser P, Mylonas I, Ruhnke M, Schaller M, Weissenbacher ER.
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [Abstract] [Full Text] [Related]

  • 16. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T, Nailis H, Dhont MA, Rodriguez-Tudela JL, Nelis HJ.
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [Abstract] [Full Text] [Related]

  • 17. Single dose oral fluconazole vs intravaginal terconazole in treatment of Candida vaginitis. Comparison and pilot study.
    Slavin MB, Benrubi GI, Parker R, Griffin CR, Magee MJ.
    J Fla Med Assoc; 1992 Oct; 79(10):693-6. PubMed ID: 1460451
    [Abstract] [Full Text] [Related]

  • 18. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
    Mendling W, Brasch J, German Society for Gynecology and Obstetrics, Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, German Society of Dermatology, the Board of German Dermatologists, German Speaking Mycological Society.
    Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
    [Abstract] [Full Text] [Related]

  • 19. Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis.
    Sekhavat L, Tabatabaii A, Tezerjani FZ.
    J Infect Public Health; 2011 Sep; 4(4):195-9. PubMed ID: 22000847
    [Abstract] [Full Text] [Related]

  • 20. Vaginal Candida parapsilosis: pathogen or bystander?
    Nyirjesy P, Alexander AB, Weitz MV.
    Infect Dis Obstet Gynecol; 2005 Mar; 13(1):37-41. PubMed ID: 16040326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.